PP
GSK icon

Pacifica Partners’s GSK GSK Stock Holding History

Pacifica Partners’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-140
Closed -$7.73K – 437
2026
Q1 		$7.73K Hold
140
– – ﹤0.01% 334
2025
Q4 		$6.95K Hold
140
– – ﹤0.01% 328
2025
Q3 		$6.37K Hold
140
– – ﹤0.01% 372
2025
Q2 		$5.4K Buy
+140
New +$5.35K ﹤0.01% 388
2021
Q1 		– Sell
-176
Closed -$8K – 420
2020
Q4 		$8K Hold
176
– – 0.01% 271
2020
Q3 		$8K Hold
176
– – 0.01% 237
2020
Q2 		$9K Hold
176
– – 0.01% 238
2020
Q1 		$8K Hold
176
– – 0.01% 249
2019
Q4 		$10K Buy
+176
New +$9.79K 0.01% 234

Other funds holding GSK

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.82B AUM
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
FVWA
Foster Victor Wealth Advisors Greenville, South Carolina $1.9B AUM 24.46% 1-Year Est. Return
SIS
Sound Income Strategies Ft Lauderdale, Florida $2.23B AUM 11.22% 1-Year Est. Return
KFP
Keystone Financial Planning Cleveland, Ohio $388M AUM 16.66% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return
TH
Transmarket Holdings Chicago, Illinois $136M AUM

Pacifica Partners's GSK Position: Q2 2026 in Review

Pacifica Partners sold out of GSK (GSK) in Q2 2026, closing a stake of 140 shares — an estimated $7.73K sold.

Pacifica Partners first reported a position in GSK in Q4 2019 and held it in 9 quarters. The position peaked at $10K in Q4 2019. 296 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Pacifica Partners reported no remaining GSK position as of Q2 2026 after selling out during the quarter.
  • Pacifica Partners sold 140 GSK shares in Q2 2026, an estimated $7.73K.
  • Pacifica Partners first reported a position in GSK in Q4 2019 and held it in 9 quarters.
  • Pacifica Partners's GSK position peaked at $10K in Q4 2019.
  • 296 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Pacifica Partners's 13F filing for Q2 2026, filed 13 Jul 2026.